It is very well known that the progression of CML in the patients is due to the distinct expression of BCR-ABL gene8 and drugs like imatinib show decrease in this expression and helps reverse the disease to a greater extent. The gene discussed is BCR; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.